Search For

The global burden of diabetes-related chronic kidney disease from 1990 to 2021, with projections to 2036

Type 1 diabetes mellitus: the liver’s role, sex-specific outcomes, and advances in disease-modifying therapies - a literature review

Evolving models of care in patients with metabolic dysfunction-associated steatotic liver disease, recognising its population burden and the impact of metabolic dysfunction on incident rates of hepatic and extrahepatic outcomes

Regulatory T cell-based therapies for type 1 diabetes: a narrative review

Duodenal mucosa resurfacing: the endoscopic silver bullet against metabolic disorders?

Physical exercise for obesity and T2DM mitigation in polycystic ovary syndrome: the role of adipose tissue

Research progress and future prospects of small-molecule glucagon-like peptide-1 receptor agonists (GLP-1RAs)

Metrnl plays a crucial role in the regulation of glycolipid metabolism

Liver fibrosis as a barometer of systemic health by gauging the risk of extrahepatic disease

Immunotherapy for type 1 diabetes

Neurophysiological assessment of peripheral neuropathy through whole plantar nerve conduction in type 2 diabetes mellitus and healthy control subjects

Obesity and diabetes in heart disease in women